Gregory Powell, MBA, PharmD

Senior Director, Safety and Clinical Innovation
GSK

Poster(s):

• (183) An Examination of How Serious Infection Are Reported in Spontaneous Reports
  Friday, August 26, 2022

  8:00 AM – 6:00 PM CEST

• (171) Concordance Between Subgroup Disproportionality Scores and PRAC Discussions of Subgroup Risk
  Sunday, August 28, 2022

  8:00 AM – 1:45 PM CEST